Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Tacrolimus ointment: utilization patterns in children under age 2 years.

Tamara Salam Housman¹, Amy B Norton, Steven R Feldman

¹Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.

Dermatology Online Journal

|September 7, 2004

Summary

Atopic dermatitis (AD) affects many children, often appearing in infancy. Current treatments like topical corticosteroids (TCS) carry risks, especially in young children, prompting a need for safer alternatives.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Time to Meaningful Clinical Response Across Approved and Emerging Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Network Meta-Analysis.

Journal of clinical medicine·2026

Same author

Response to commentary: Aligning dermatology continuing certification and quality outcomes through research.

Journal of the American Academy of Dermatology·2026

Same author

Retirement Patterns in Mohs Micrographic Surgeons and General Dermatologists: A Medicare Part B and Part D Analysis.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

Same author

Mandatory recertification and practice patterns of dermatologists: A Medicare Part B and Part D Database analysis.

Journal of the American Academy of Dermatology·2026

Same author

Reply to Torres et al, "Reply to Woodie et al, 'Elevated risk of active tuberculosis with interleukin-17, interleukin-23, interleukin-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX'".

Journal of the American Academy of Dermatology·2026

Same author

Modifiable Factors Such as Nicotine Use, Obesity, Vitamin D Deficiency, Diabetes, and Hypertension Predict Acute Complications of Dermatologic Surgery.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

Area of Science:

Pediatric Dermatology
Allergen and Immune System

Background:

Atopic dermatitis (AD) is a prevalent eczematous skin condition affecting 10-17% of children, with onset frequently in the first year of life.
Standard AD treatment for young children includes conservative measures and low-potency topical corticosteroids (TCS).
Concerns exist regarding TCS safety in pediatrics due to potential side effects and systemic absorption, leading to hypothalamic-pituitary-adrenal axis suppression and growth retardation.

Purpose of the Study:

To review the current treatment principles for atopic dermatitis in young children.
To highlight the limitations and potential complications associated with topical corticosteroid use in this population.
To underscore the challenges in managing AD in infants and the need for approved therapies.

Main Methods:

Related Experiment Videos

Literature review of existing studies and clinical guidelines on atopic dermatitis management in pediatric populations.
Analysis of the risks and benefits of conservative measures and topical corticosteroids.
Examination of systemic absorption risks and potential adverse effects in infants and young children.

Main Results:

Conservative measures like avoiding irritants and using emollients are foundational but often insufficient.
Low-potency TCS are standard, but mid- and high-potency are reserved for severe cases due to risks.
Pediatric patients face higher systemic absorption risks, potentially causing significant adverse effects, and many treatments lack FDA approval for children under two.

Conclusions:

Conservative management and low-potency TCS are initial approaches for pediatric atopic dermatitis.
The risk of adverse effects from TCS, including systemic absorption and growth issues, is a significant concern in young children.
There is a clinical need for effective and safe treatments for atopic dermatitis in children under two years old, as current options are often used off-label.